Busulfan
- Product NDC
- 70860-216
- 11-digit product format
- 708600216
- Labeler code
- 70860
- Product ID
- 70860-216_8189e34d-4b3d-4a39-a42f-870cfd05baaf
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- busulfan
- Dosage form
- INJECTION, SOLUTION, CONCENTRATE
- Route
- INTRAVENOUS
- Labeler
- Athenex Pharmaceutical Division, LLC.
- Application
- ANDA205106
- Marketing category
- ANDA
- Marketing start
- 2019-02-10
- Marketing end
- 2021-07-31
- Substance
- BUSULFAN
- Active strength
- 6 mg/mL
- Pharmacologic classes
- Alkylating Activity [MoA],Alkylating Drug [EPC]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70860-216-10 | 70860021610 | 8 VIAL in 1 CARTON (70860-216-10) > 10 mL in 1 VIAL (70860-216-41) | 8 vial | 2019-02-10 | 2021-07-31 | No | No | Current |